Influence of body mass index on clinicopathologic features, surgical morbidity and outcome in patients with endometrial cancer

Archives of Gynecology and Obstetrics

Volumn 286, Issue 5, 2012, Pages 1269-1276

  AkbayIr, Ozgur ^a   CorbacIoglu Esmer, Aytul ^a,b   Numanoglu, Ceyhun ^a   CIlesIz Goksedef, B Pinar ^c   Akca, Aysu ^a   BakIr, Lale Vuslat ^a   Kuru, Oguzhan ^a  

^a Kanuni Sultan Suleyman Teaching and Research Hospital   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c HASEKI EDUCATION AND RESEARCH HOSPITAL   (Turkey)

Author keywords

BMI; Body mass index; Endometrial cancer; Morbidity; Obesity

Indexed keywords

ABDOMINAL HYSTERECTOMY; ADULT; ARTICLE; BLEEDING; BODY MASS; BRACHYTHERAPY; BREAST CANCER; CANCER GRADING; CANCER INCIDENCE; CANCER INVASION; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER THERAPY; COLON CANCER; COMORBIDITY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CANCER; FEMALE; HISTOPATHOLOGY; HOSPITALIZATION; HUMAN; HUMAN TISSUE; HYPERTENSION; HYPOTHYROIDISM; LUNG DISEASE; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MORBIDITY; OBESITY; OPERATION DURATION; OVARIECTOMY; OVERALL SURVIVAL; PARAAORTIC LYMPH NODE; PELVIS LYMPH NODE; PELVIS LYMPHADENECTOMY; PERITONEAL FLUID; PEROPERATIVE CARE; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; RETROSPECTIVE STUDY; RISK FACTOR; SURGICAL MORBIDITY; SURVIVAL TIME; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ADENOCARCINOMA; AGE FACTORS; AGED; AORTA; BODY MASS INDEX; CHEMOTHERAPY, ADJUVANT; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYSTERECTOMY; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OBESITY; OPERATIVE TIME; OVARIECTOMY; PELVIS; PERITONEAL CAVITY; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84868098214     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-012-2431-2     Document Type: Article

References (18)

1. Everett E, Tamimi H, Greer B, Swisher E, Paley P, Mandel L, Goff B (2003) The effect of body mass index on clinical/pathologic features, surgical morbidity, and outcome in patients with endometrial cancer. Gynecol Oncol 90:150-157
2. Fader AN, Arriba LN, Frasure HE, von Gruenigen VE (2009) Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship. Gynecol Oncol 114:121-127
3. Zhang Y, Liu Z, Yu X, Zhang X, Lü S, Chen X, Lü B (2010) The association between metabolic abnormality and endometrial cancer: a large case-control study in China. Gynecol Oncol 117:41-46
4. McCourt CK, Mutch DG, Gibb RK, Rader JS, Goodfellow PJ, Trinkaus K, Powell MA (2007) Body mass index: relationship to clinical, pathologic and features of microsatellite instability in endometrial cancer. Gynecol Oncol 104:535-539
5. Cymbaluk A, Chudecka-Glaz A, Rzepka-Górska I (2008) Leptin levels in serum depending on body mass index in patients with endometrial hyperplasia and cancer. Eur J Obstet Gynecol 136:74-77
6. Reeves KW, Carter GC, Rodabough RJ, Lane D, McNeeley SG, Stefanick ML, Paskett ED (2011) Obesity in relation to endometrial cancer risk and disease characteristics in the women's health initiative. Gynecol Oncol 121:376-382
7. Jeong NH, Lee JM, Lee JK, Kim JW, Cho CH, Kim SM, Seo SS, Park CY, Kim KT, Lee J (2010) Role of body mass index as a risk and prognostic factor of endometrioid uterine cancer in Korean women. Gynecol Oncol 118:24-28
8. Pavelka JC, Ben-Shachar I, Fowler JM, Rarnirez NC, Copeland LJ, Eaton LA, Manolitsas TP, Cohn DE (2004) Morbid obesity and endometrial cancer: surgical, clinical, and pathologic outcomes in surgically managed patients. Gynecol Oncol 95:588-592
9. Munstedt K, Wagner M, Kullmer U, Hackethal A, Frankee FE (2008) Influence of body mass index on prognosis in gynecological malignancies. Cancer Causes Control 19(9):909-916
10. Martra F, Kunos C, Gibbons H, Zola P, Galleto L, DeBernardo R, von Gruenigen V (2008) Adjuvant treatment and survival in obese women with endometrial cancer: an international collaborative study. Am J Obstet Gynecol 198:89.e1-89.e8
11. Anderson B, Connor JP, Andrews JI, Davic CS, Buller RE, Sorosky CI, Benda JA (1996) Obesity and prognosis in endometrial cancer. Am J Obstet Gynecol 174:1171-1178
12. Chia VM, Newcomb PA, Trentham-Dietz A, Hampton JM (2007) Obesity, diabetes, and other factors in relation to survival after endometrial cancer diagnosis. Int J Obstet Gynecol 17:441-446
13. Speroff L, Fritz FA (eds) (2005) Obesity. Clinical gynecologic endocrinology and infertility. Lippincott Williams & Wilkins, Philadelphia
14. Schmeler KM, Soliman PT, Sun CC, Slomovitz BM, Gershenson DM, Lu KH (2005) Endometrial cancer in young, normal-weight women. Gynecol Oncol 99:388-392
15. Lachance JA, Everett EN, Greer B, Mandel L, Swisher E, Tamimi H, Goff B (2006) The effect of age on clinical/pathologic features, surgical morbidity, and outcome in patients with endometrial cancer. Gynecol Oncol 101:470-475
16. Studzjinski Z, Zajevwski W (1982) Factors affecting the survival of 121 patients treated for endometrial carcinoma at a Polish hospital. Arch Gynecol Obstet Gynecol 143:569-573
17. Steiner E, Eicher O, Sagemuller J, Schmidt M, Pilch H, Tanner B et al (2003) Multivariate independent prognostic factors in endometrial carcinoma: a clinicopthologic study in 181 patients: 10 years experince at the Department of Obstetrics and Gynecology in Mainz University. Int J Gynecol Cancer 13:197-203
18. Folsom AR, Anderson KE, Sweeney C, Jacobs DR Jr (2004) Diabetes as a risk factor for death following endometrial cancer. Gynecol Oncol 94:740-745